Literature DB >> 1233992

Prednisolone levels in the plasma and urine: a study of two preparations in man.

J English, J Chakraborty, V Marks, D J Trigger, A G Thomson.   

Abstract

1. A competitive protein binding method was used to measure prednisolone and cortisol in blood and urine of volunteers given prednisolone by mouth (15 mg) in the standard tablet form and a fortnight later a regulated release formulation of prednisolone metasulphobenzoate containing an equivalent amount of prednisolone. 3. Plasma prednisolone levels rose rapidly after the standard tablet and more slowly after the regulated release form. The normal activity of the hypothalamic-pituitary-adrenal axis as measured by the 09.00 h plasma cortisol concentration was present 24 h after ingestion of the regulated release preparation. In contrast, the 09.00 h plasma cortisol level was reduced in subjects 24 h after receiving prednisolone in the standard tablet form.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233992      PMCID: PMC1402596          DOI: 10.1111/j.1365-2125.1975.tb02779.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN.

Authors:  J G HARTER; W J REDDY; G W THORN
Journal:  N Engl J Med       Date:  1963-09-19       Impact factor: 91.245

2.  Differences in metabolism of prednisolone-C14 and cortisol-C14.

Authors:  A A SANDBERG; W R SLAUNWHITE
Journal:  J Clin Endocrinol Metab       Date:  1957-09       Impact factor: 5.958

3.  Delta1-Hydrocortisone: plasma 17-hydroxycorticosteroid concentrations following oral and I.V. administration.

Authors:  R S ELY; A K DONE; V C KELLEY
Journal:  Proc Soc Exp Biol Med       Date:  1956-03

4.  Measurement of plasma prednisolone by a competitive protein-binding assay.

Authors:  D H Sandberg; C Z Bacallao; W W Cleveland
Journal:  Biochem Med       Date:  1970-12

5.  Radioimmunoassay for prednisolone.

Authors:  W A Colburn; R H Buller
Journal:  Steroids       Date:  1973-06       Impact factor: 2.668

6.  Adrenocortical responsiveness after alternate-day corticosteroid therapy.

Authors:  G L Ackerman; C M Nolsn
Journal:  N Engl J Med       Date:  1968-02-22       Impact factor: 91.245

7.  Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone.

Authors:  S D Grant; P H Forsham; V C DiRaimondo
Journal:  N Engl J Med       Date:  1965-11-18       Impact factor: 91.245

8.  Sustained-release formulation of prednisolone administered orally to man.

Authors:  P F D'Arcy; J P Griffin; J S Jenkins; W F Kirk; A W Peacock
Journal:  J Pharm Sci       Date:  1971-07       Impact factor: 3.534

9.  Conversion of cortisone to cortisol and prednisone to prednisolone.

Authors:  J S Jenkins; P A Sampson
Journal:  Br Med J       Date:  1967-04-22
  9 in total
  12 in total

1.  A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method.

Authors:  J Chakraborty; J English; V Marks; M C Dumasia; D J Chapman
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

Authors:  P J Morrison; I D Bradbrook; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

3.  Bioavailability of prednisolone tablets.

Authors:  A V Tembo; M R Hallmark; E Sakmar; H G Bachmann; D J Weidler; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-06

4.  In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery.

Authors:  C S Leopold; D R Friend
Journal:  J Pharmacokinet Biopharm       Date:  1995-08

Review 5.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

6.  A radioimmunoassay procedure for dexamethasone: plasma and urine levels in man.

Authors:  J English; J Chakraborty; V Marks; A Parke
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

7.  Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema.

Authors:  D A Lee; G M Taylor; V H James; G Walker
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

8.  Rectally administered prednisolone--evidence for a predominantly local action.

Authors:  D A Lee; M Taylor; V H James; G Walker
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

Review 9.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

10.  Plasma prednisolone measurements in renal transplant patients.

Authors:  J Chakraborty
Journal:  Ulster Med J       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.